Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood test could revolutionize early dementia care

NCT ID NCT07140744

First seen Nov 03, 2025 · Last updated Jun 18, 2026 · Updated 32 times

Summary

This study is testing whether a new blood test (P-tau217) can help doctors make better decisions for people with memory complaints. About 7,000 participants will be split into groups where doctors either see the test results or not. The goal is to see if the test leads to earlier referrals, counseling, or treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SUBJECTIVE COGNITIVE IMPAIRMENT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • SiteRx Virtual Site

    RECRUITING

    New York, New York, 10013, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

The condition(s) this trial relates to.

subjective cognitive decline

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.